X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15334) 15334
Publication (1665) 1665
Book Review (215) 215
Book Chapter (153) 153
Conference Proceeding (26) 26
Dissertation (19) 19
Magazine Article (10) 10
Book / eBook (7) 7
Newsletter (6) 6
Data Set (4) 4
Paper (2) 2
Reference (2) 2
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (7628) 7628
humans (7433) 7433
index medicus (6374) 6374
male (6087) 6087
phosphodiesterase inhibitors - pharmacology (3665) 3665
rats (2983) 2983
pharmacology & pharmacy (2619) 2619
phosphodiesterase (2492) 2492
female (2308) 2308
mice (2138) 2138
sildenafil citrate (1984) 1984
sildenafil (1902) 1902
biochemistry & molecular biology (1869) 1869
erectile dysfunction (1793) 1793
phosphodiesterase inhibitors - therapeutic use (1766) 1766
middle aged (1712) 1712
cyclic amp - metabolism (1589) 1589
urology & nephrology (1442) 1442
erectile dysfunction - drug therapy (1428) 1428
adult (1404) 1404
neurosciences (1382) 1382
cell biology (1366) 1366
dose-response relationship, drug (1352) 1352
analysis (1201) 1201
3',5'-cyclic-amp phosphodiesterases - antagonists & inhibitors (1192) 1192
aged (1177) 1177
cells, cultured (1161) 1161
expression (1140) 1140
camp (1099) 1099
tadalafil (1021) 1021
treatment outcome (990) 990
in vitro techniques (985) 985
impotence (971) 971
cyclic gmp - metabolism (969) 969
rats, sprague-dawley (967) 967
3',5'-cyclic-amp phosphodiesterases - metabolism (964) 964
phosphodiesterase inhibitors (958) 958
signal transduction (951) 951
nitric oxide (950) 950
phosphoric diester hydrolases - metabolism (937) 937
phosphorylation (935) 935
nitric-oxide (920) 920
activation (903) 903
research (895) 895
cyclic nucleotide phosphodiesterases, type 4 (890) 890
piperazines - therapeutic use (881) 881
physiology (843) 843
article (842) 842
enzyme inhibitors - pharmacology (831) 831
purines (827) 827
rolipram (826) 826
phosphodiesterase 5 inhibitors - therapeutic use (823) 823
piperazines - pharmacology (822) 822
proteins (815) 815
disease models, animal (794) 794
sulfones (782) 782
phosphodiesterases (780) 780
rats, wistar (761) 761
cells (747) 747
inhibition (741) 741
enzymes (737) 737
inhibitors (726) 726
time factors (724) 724
cardiac & cardiovascular systems (712) 712
physiological aspects (708) 708
apoptosis (705) 705
cyclic nucleotide phosphodiesterases, type 5 (683) 683
cgmp (677) 677
kinetics (664) 664
care and treatment (662) 662
double-blind (654) 654
cyclic amp (638) 638
inflammation (635) 635
cyclic-nucleotide phosphodiesterases (632) 632
in-vitro (629) 629
chemistry, medicinal (620) 620
health aspects (616) 616
men (604) 604
phosphodiesterase inhibitors - administration & dosage (600) 600
calcium - metabolism (591) 591
drug therapy (590) 590
research article (583) 583
signal transduction - drug effects (581) 581
gene expression (575) 575
cell line (569) 569
mice, inbred c57bl (562) 562
1-methyl-3-isobutylxanthine - pharmacology (550) 550
rodents (547) 547
medicine (543) 543
medicine & public health (527) 527
multidisciplinary sciences (523) 523
nitric-oxide synthase (522) 522
double-blind method (514) 514
risk factors (512) 512
3',5'-cyclic-gmp phosphodiesterases - antagonists & inhibitors (509) 509
hypertension (509) 509
efficacy (508) 508
respiratory system (508) 508
phosphodiesterase inhibitors - adverse effects (503) 503
sphingomyelin phosphodiesterase - metabolism (499) 499
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15150) 15150
Japanese (161) 161
German (76) 76
French (62) 62
Russian (50) 50
Chinese (37) 37
Spanish (22) 22
Korean (10) 10
Portuguese (9) 9
Italian (4) 4
Polish (4) 4
Turkish (4) 4
Dutch (3) 3
Bulgarian (2) 2
Czech (2) 2
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 02/2019, Volume 75, Issue 2, pp. 329 - 340
Peyronie's disease (PD) is a fibrotic disorder of the penile tunica albuginea, characterised by the formation of a localised fibrous plaque that can lead to... 
Phenotypic screening | Peyronie's disease | Myofibroblast | Fibrosis | Phosphodiesterase type 5 inhibitor | Oestrogen receptor modulator | Fibroblast | Fibroproliferative | Tunica albuginea | COMBINATION THERAPY | TAMOXIFEN | RAT MODEL | FIBROBLASTS | GROWTH-FACTOR-BETA | Phosphodiesterase type | CONTRACTION | MEN | UROLOGY & NEPHROLOGY | MYOFIBROBLASTS | 5 inhibitor | SMAD
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 1, pp. 124 - 133
Journal Article
Current Sports Medicine Reports, ISSN 1537-890X, 11/2017, Volume 16, Issue 6, pp. 443 - 447
Journal Article
Journal Article
by Feng, SJ and Zhou, L and Liu, QY and He, Q and Liao, BH and Wei, X and Li, H and Wang, KJ and Zhu, YC
MEDICINE, ISSN 0025-7974, 01/2018, Volume 97, Issue 3, p. e9601
Phosphodiesterase type 5 (PDE5) inhibitors are recommended for patients with erectile dysfunction by American Urological Association and European Association... 
MEDICINE, GENERAL & INTERNAL | phosphodiesterase type 5 inhibitor | SILDENAFIL | QUALITY | melanoma | systematic review | risk factor | CANCER | ERECTILE DYSFUNCTION
Journal Article